Selpercatinib efficacy and safety in patients with RET-altered thyroid cancer: a clinical trial update

Authors
Category Primary study
ConferenceJournal of clinical oncology
Year 2021
This article has no abstract
Epistemonikos ID: b9ef2b715043d26cec3e8b16284e3bdb9c5ebf36
First added on: Dec 20, 2022